1. Characterization of antidiabetic effects of Dendrobium officinale derivatives in a mouse model of type 2 diabetes mellitus
   Dong Peng et al, 2023, Food Chemistry CrossRef
2. Treatment of Nonalcoholic Fatty Liver Disease through Changes in Gut Microbiome and Intestinal Epithelial Barrier
   Hassan M. Heshmati, 2021, Advances in Hepatology CrossRef
3. Effect of Trichinella spiralis-Derived Antigens on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice
   Yong Yang et al, 2024, ACS Pharmacology & Translational Science CrossRef
4. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
   Sara Jarmakiewicz-Czaja et al, 2022, Canadian Journal of Gastroenterology and Hepatology CrossRef
5. Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
   Guang-Yan Wang et al, 2023, World Journal of Gastroenterology CrossRef
6. Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
   Nicolás Ortiz-López et al, 2024, Frontiers in Medicine CrossRef
7. Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice
   Ji Eun Kim et al, 2022, Foods CrossRef
8. Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
   Ki-Kwang Oh et al, 2022, Current Issues in Molecular Biology CrossRef
9. Intestinal Dysbiosis and Non-Alcoholic Fatty Liver Disease
   Teresa Auguet et al, 2021, Human Microbiome CrossRef